We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

011780:KRXKumho Petrochemical Co., Ltd. Analysis

Data as of 2026-05-27 - not real-time

₩140,000.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Kumho Petro Chemical is trading at 140,000 KRW, just below its 20‑day SMA of 142,180 KRW but comfortably above the 50‑day SMA of 134,264 KRW, suggesting a short‑term price pressure point. The RSI of 50.2 indicates a neutral momentum environment, while the MACD histogram remains negative, flagging a bearish tilt despite the overall bullish trend direction. Support sits at 129,100 KRW with resistance near 155,300 KRW, and the stock’s volatility is high at ~72% over the past 30 days, though its beta of 0.60 points to lower market‑wide sensitivity.
Fundamentally, the DCF fair value of 203,054 KRW implies an upside of roughly 21%, and the dividend yield of 1.14% with a modest payout ratio of 16.6% appears sustainable given strong operating cash flow. However, revenue has contracted by 12% and margins remain thin, underscoring the need for operational improvements.
Given the decreasing volume trend and a market sentiment index in the “Extreme Greed” zone, the stock may attract value‑seeking investors, but the combination of high volatility and modest profitability calls for disciplined positioning across time horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just below the 20‑day SMA
  • Negative MACD histogram suggesting short‑term bearish pressure
  • Decreasing volume trend reducing momentum confidence

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF valuation indicates ~21% upside
  • Sustainable dividend yield with low payout ratio
  • Low beta and bullish overall trend supporting price appreciation

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Cyclical specialty‑chemicals exposure offering growth tailwinds
  • Consistent cash flow generation despite thin margins
  • Valuation gap relative to fair value providing margin of safety

Key Metrics & Analysis

Financial Health

Revenue Growth-12.00%
Profit Margin4.21%
P/E Ratio8.3
ROE4.74%
ROA2.02%
Debt/Equity16.14
Op. Cash Flow₩715.3B
Free Cash Flow₩398.7B

Technical Analysis

TrendBullish
RSI50.2
Support₩129,100.00
Resistance₩155,300.00
MA 20₩142,180.00
MA 50₩134,264.00
MA 200₩124,347.75
MACDBearish
VolumeDecreasing
Fear & Greed Index91.46

Valuation

Fair Value₩203,053.75
Target Price₩169,133.33
Upside/Downside20.81%
GradeUndervalued
TypeValue
Dividend Yield1.14%

Risk Assessment

Beta0.60
Volatility71.99%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.